MedTrace Logo

Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing

NCT03475979 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1564

Last updated 2020-11-30

No results posted yet for this study

Summary

Study Purpose:

A multicenter prospective study to evaluate the outcome of second breast cancer surveillance with abbreviated breast MR (AB-MR) or ultrasound (US) in addition to annual mammography in women with BRCA1/2 mutation testing

Study Scheme:

* AB-MR, US, and digital mammography will be performed on the same day and interpreted independently at baseline and then after 1 year.
* After completion of study, patients are followed-up for at least 1 year.

Conditions

  • Breast Cancer
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Recurrent Breast Cancer
  • Metachronous Neoplasm

Sponsors & Collaborators

  • Korean Society of Breast Imaging & Korean Society For Breast Screening

    collaborator UNKNOWN

  • Bayer

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Woo Kyung Moon, MD, PhD · Professor

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03475979 on ClinicalTrials.gov